肢端肥大症
Pegvisomant公司
卡麦角林
帕西雷肽
医学
生长抑素
药物治疗
内科学
内分泌学
生长激素
激素
催乳素
作者
Leandro Kasuki,Elisa Baranski Lamback,Ximene Antunes,Mônica R. Gadelha
标识
DOI:10.1080/17446651.2023.2293107
摘要
Introduction Medical treatment of acromegaly is based in a `trial and error` approach. First-generation somatostatin receptor ligands (fg-SRL) are prescribed as first-line medical therapy to the vast majority of patients, despite lack of disease control in approximately 60% of patients. However, other drugs used in acromegaly treatment are available (cabergoline, pasireotide and pegvisomant).
科研通智能强力驱动
Strongly Powered by AbleSci AI